<img alt="" src="https://secure.pass8heal.com/222507.png" style="display:none;">

    TecTraum Announces Completion of Clinical Trial

    TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced the completion of the pro2cool®clinical trial.

    TecTraum’s pro2cool Receives FDA Designation as Breakthrough Device

    The FDA has designated TecTraum's pro2cool® - dedicated to providing the world’s first point-of-care treatment for concussions - as a Breakthrough Device.

    PARTNER, INNOVATE, COMMERCIALIZE, DISRUPT: NS at CES 2019

    Nottingham Spirk exhibited at CES for the first time in 2019, and we invited a few of our client-partners to show the world what we achieved together.

    NS Biomedical Engineers: “It’s About Making People’s Lives Better”

    This month we are featuring our Biomedical Engineering Team and their thoughts about Nottingham Spirk's approach to medical device design.